Luminous Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Quantum Exponential, Final Results

The breakthrough device designation for Oxford VR follows a clinical trial that demonstrated the effectiveness of its VR therapy.

So-called ‘Deep Tech’ venture capital has been experiencing a wave of interest in the couple last years with several new funds launching. Many are focused on the European market, which has a deep bench (no pun intended) of talent and innovation, thanks in part to its many excellent universities. The latest is Outsized Ventures, a […]

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. theoretical treatments but can’t actually make the molecules. The company’s system enters play when you have some exotic new compound you want to make in order to test it in real life, but don’t know how to make it. After all, these ...

Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. Molecule.one went on stage at Disrupt SF 2019's Startup Battlefield, where they explained the difficulty faced by the drug discovery industry, basically that they come up with lots of theoretical treatments but can't actually make the molecules.